Time-efficient Strategies in Human IPS Cell-derived Pancreatic Progenitor Differentiation and Cryopreservation: Advancing Towards Practical Applications

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2024 Dec 19

PMID 39695795

Authors

Elena Genova

Paola Rispoli

Yue Fengming

Johkura Kohei

Matteo Bramuzzo

Roberta Bulla

Marianna Lucafo

Rosalba Monica Ferraro

Giuliana Decorti

Gabriele Stocco

Affiliations

Soon will be listed here.

Abstract

Background: Differentiation of patient-specific induced pluripotent stem cells (iPS) helps researchers to study the individual sensibility to drugs. However, differentiation protocols are time-consuming, and not all tissues have been studied. Few works are available regarding pancreatic exocrine differentiation of iPS cells, and little is known on culturing and cryopreserving these cells.

Methods: We differentiated the iPS cells of two pediatric Crohn's disease patients into pancreatic progenitors and exocrine cells, adapting and shortening a protocol for differentiating embryonic stem cells. We analyzed the expression of key genes and proteins of the differentiation process by qPCR and immunofluorescence, respectively. We explored the possibility of keeping differentiated cells in culture and freezing and thawing them to shorten the time needed for the differentiation. We analyzed the cell cycle of undifferentiated and differentiated cells by flow cytometry.

Results: The analysis of mRNA levels of key pancreatic differentiation genes PDX1 and pancreatic amylase indicate that iPS cells were successfully differentiated into pancreatic exocrine cells with expression of PDX1 (one way ANOVA p < 0.0001), and the two isoforms of amylase (one way ANOVA p < 0.05) significantly higher in exocrine cells in comparison to iPS cells. Differentiation efficiency was also confirmed by immunofluorescence analysis of PDX1 and amylase. We confirmed the possibility of shortening the time necessary for obtaining pancreatic cells without losing differentiation efficiency. Pancreatic progenitors and exocrine cells were maintained in culture and cryopreserved. Interestingly, the stemness marker OCT4 resulted significantly lower after subculturing (OCT4 p < 0.001; one-way ANOVA) and after freezing and thawing procedures (p < 0.05, one-way ANOVA) suggesting a reduction of undifferentiated stem cells leading to a purer population of pancreatic progenitor cells. Also, the stemness marker NANOG resulted lower after passaging, corroborating this result.

Conclusions: In this work, we optimized the generation of patient-specific pancreatic differentiated cells and laid the foundation for creating a bank of patient-specific pancreatic lines exploitable for tailored pharmacological assays.

Trial Registration: The study was approved by the Ethical Committee of the Institute of Maternal and Child Health IRCCS Burlo Garofolo, with approval number 1556 (internal ID RC 44/22).

References

Chetty S, Pagliuca F, Honore C, Kweudjeu A, Rezania A, Melton D . A simple tool to improve pluripotent stem cell differentiation. Nat Methods. 2013; 10(6):553-6. PMC: 3694177. DOI: 10.1038/nmeth.2442. View

Genova E, Cavion F, Lucafo M, De Leo L, Pelin M, Stocco G . Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events. World J Stem Cells. 2019; 11(12):1020-1044. PMC: 6904863. DOI: 10.4252/wjsc.v11.i12.1020. View

Sun Y, Hurley K, Villacorta-Martin C, Huang J, Hinds A, Gopalan K . Heterogeneity in Human Induced Pluripotent Stem Cell-derived Alveolar Epithelial Type II Cells Revealed with ABCA3/SFTPC Reporters. Am J Respir Cell Mol Biol. 2021; 65(4):442-460. PMC: 8525201. DOI: 10.1165/rcmb.2020-0259OC. View

Aboul-Soud M, Alzahrani A, Mahmoud A . Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening. Cells. 2021; 10(9). PMC: 8467501. DOI: 10.3390/cells10092319. View

Inui J, Ueyama-Toba Y, Mitani S, Mizuguchi H . Development of a method of passaging and freezing human iPS cell-derived hepatocytes to improve their functions. PLoS One. 2023; 18(5):e0285783. PMC: 10194907. DOI: 10.1371/journal.pone.0285783. View

Sousa M, Correia B, Branco A, Rodrigues A, Ramalho-Santos J . Effects of DMSO on the Pluripotency of Cultured Mouse Embryonic Stem Cells (mESCs). Stem Cells Int. 2020; 2020:8835353. PMC: 7584961. DOI: 10.1155/2020/8835353. View

Nakamura A, Wong Y, Venturato A, Michaut M, Venkateswaran S, Santra M . Long-term feeder-free culture of human pancreatic progenitors on fibronectin or matrix-free polymer potentiates β cell differentiation. Stem Cell Reports. 2022; 17(5):1215-1228. PMC: 9133655. DOI: 10.1016/j.stemcr.2022.03.013. View

Schaffer A, Freude K, Nelson S, Sander M . Nkx6 transcription factors and Ptf1a function as antagonistic lineage determinants in multipotent pancreatic progenitors. Dev Cell. 2010; 18(6):1022-9. PMC: 3133668. DOI: 10.1016/j.devcel.2010.05.015. View

Philonenko E, Shutova M, Chestkov I, Lagarkova M, Kiselev S . Current progress and potential practical application for human pluripotent stem cells. Int Rev Cell Mol Biol. 2011; 292:153-96. DOI: 10.1016/B978-0-12-386033-0.00004-9. View

10.

Jennings R, Scharfmann R, Staels W . Transcription factors that shape the mammalian pancreas. Diabetologia. 2020; 63(10):1974-1980. PMC: 7476910. DOI: 10.1007/s00125-020-05161-0. View

11.

Trott J, Tan E, Ong S, Titmarsh D, Denil S, Giam M . Long-Term Culture of Self-renewing Pancreatic Progenitors Derived from Human Pluripotent Stem Cells. Stem Cell Reports. 2017; 8(6):1675-1688. PMC: 5470345. DOI: 10.1016/j.stemcr.2017.05.019. View

12.

Rispoli P, Scandiuzzi Piovesan T, Decorti G, Stocco G, Lucafo M . iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy. WIREs Mech Dis. 2023; 16(1):e1630. DOI: 10.1002/wsbm.1630. View

13.

Kallas A, Pook M, Trei A, Maimets T . SOX2 Is Regulated Differently from NANOG and OCT4 in Human Embryonic Stem Cells during Early Differentiation Initiated with Sodium Butyrate. Stem Cells Int. 2014; 2014:298163. PMC: 3951062. DOI: 10.1155/2014/298163. View

14.

Konagaya S, Iwata H . Chemically defined conditions for long-term maintenance of pancreatic progenitors derived from human induced pluripotent stem cells. Sci Rep. 2019; 9(1):640. PMC: 6345937. DOI: 10.1038/s41598-018-36606-7. View

15.

Yoder M . Differentiation of pluripotent stem cells into endothelial cells. Curr Opin Hematol. 2015; 22(3):252-7. PMC: 4429532. DOI: 10.1097/MOH.0000000000000140. View

16.

Miyatsuka T, Kaneto H, Shiraiwa T, Matsuoka T, Yamamoto K, Kato K . Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev. 2006; 20(11):1435-40. PMC: 1475756. DOI: 10.1101/gad.1412806. View

17.

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

18.

Jiang Y, Chen C, Randolph L, Ye S, Zhang X, Bao X . Generation of pancreatic progenitors from human pluripotent stem cells by small molecules. Stem Cell Reports. 2021; 16(9):2395-2409. PMC: 8452541. DOI: 10.1016/j.stemcr.2021.07.021. View

19.

Ma D, Tang S, Song J, Wu Q, Zhang F, Xing Y . Culturing and transcriptome profiling of progenitor-like colonies derived from adult mouse pancreas. Stem Cell Res Ther. 2017; 8(1):172. PMC: 5530554. DOI: 10.1186/s13287-017-0626-y. View

20.

Czysz K, Minger S, Thomas N . DMSO efficiently down regulates pluripotency genes in human embryonic stem cells during definitive endoderm derivation and increases the proficiency of hepatic differentiation. PLoS One. 2015; 10(2):e0117689. PMC: 4320104. DOI: 10.1371/journal.pone.0117689. View